New Product Development
[Report of 250 Pages] The market for bioabsorbable stents was valued at US$ 159.6 million in 2021 and is anticipated to reach US$ 165.4 million by the end of 2022. The market’s sales are anticipated to grow at a CAGR of 4.2% and surpass US$ 248.5 Mn in 2032. According to a recent study, the …
Continue reading “Bioabsorbable Stents Market surpassing ~US$ 248.5 Million in 2032”
The worldwide demand for hypochlorite bleach market is estimated at US$ 289.4 million estimated in 2022, forecast a CAGR of 5.4% valued at US$ 487.9 million from 2022 to 2032. The growth is attributed to growing demand for paper and board in emerging markets. Between 2016 and 2021, the Hypochlorite Bleach Market recorded a CAGR of 4.6%. Hypochlorite …
[314 Pages Report] According to a recent study by Future Market Insights (FMI), the global dry eye syndrome market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 4.52 Bn in 2021 to around US$ 8.84 Bn by 2031. This reflects a cumulative CAGR of around 7.0% over the forecast period (2022-2031). Dry eye syndrome …
The global ethanol market is anticipated to witness stable growth by registering a healthy CAGR of 4.6% over the projection period from 2022 to 2032. The global market is predicted to reach US$ 109 Bn in 2022 and surpass US$ 170 Bn by the end of 2032. As per the historic estimations, the ethanol market …
Continue reading “Ethanol Market Is Expected To See a growth of 4.6% | Future Market Insights”
The global hidradenitis suppurativa (HS) treatment market is expected to surpass an impressive valuation of US$ 763.6 million in 2023 and is projected to reach US$ 1,240.9 million by 2033, growing at a CAGR of 4.97%. Hidradenitis suppurativa market is currently having vast pipeline therapies targeting interleukins, including (i.e., IL-17, IL-1), anti-TNF, JAKi, and anti-complement factor. The …
The Cardiovascular Ultrasound market revenues were estimated at US$ 1.2 Billion in 2021 and is anticipated to grow at a CAGR of 7.2% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 2.6 Billion. The market is predicted to grow as preventative medicine becomes more widely used and …
The global takotsubo syndrome therapeutics market is predicted to exceed an impressive valuation of US$ 2.85 Billion in 2033, with a compound annual growth rate (CAGR) of 6.1% estimated from 2023 to 2033. In both industrialized and developing economies, cardiovascular diseases are the leading cause of death. The rising prevalence of cardiovascular problems such as valvular heart …
The global Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of6% in the forecast period 2023-2033. The market for Congenital Hyperinsulinism registered a CAGR of 4% in the historical period 2017-2022. The increasing prevalence of Congenital Hyperinsulinism disease is …
According to a recent report published by Future Market Insights, demand for cannabis use disorder treatment is poised to grow at a CAGR of 4.9% from 2023 to 2033. By the end of the aforementioned period of assessment, a valuation worth US$ 2.66 billion is anticipated. Today’s global cannabis market is measured in billions of dollars, which …
Continue reading “Cannabis Use Disorder Treatment Market to reach US$ 2.66 billion by 2033”
The global Chloangiocarcinoma Therapeutics Market is anticipated to reach a market value of US$ 800 Million in 2023 and US$ 975.20 Million by registering a CAGR of 2% from 2023 to 2033. Inflammatory bowel disease, exposure to specific toxins, and changes in bile duct anatomy are all factors contributing to the growth of the cholangiocarcinoma …
